Managing macular degeneration; a community information sessionOctober 3, 2012
The Centre for Eye Research Australia (CERA) will present a free community information session on the latest research in macular degeneration, a common eye disease, from 9.30am on Wednesday 17 October 2012.
Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in people over the age of 50 years in Australia. In AMD, the central area of the retina (called the macula) deteriorates and this eventually could lead to central vision loss. Those with a family history are four times more likely to develop the disease.
This annual information session will be a valuable opportunity for members of the public to meet the experts in the field and learn more about the recent developments in AMD research and management. Topics covered will include current and future approaches to managing AMD, coping with central vision loss and an update on AMD research.
Hosted by CERA’s Head of Macular Research Unit, Professor Guymer, the event includes presentations by Dr John Stokes, Inservio Medical Education, Mr Patrick Moore, Macular Vision Loss Support Society of Australia, and Mr Rob Cummins, Macular Degeneration Foundation.
“This is a great opportunity for anyone interested in learning more about this common eye condition,” said Professor Guymer. “In particular, we’ll be exploring how to cope with vision loss and what support is available to help you manage your condition and continue to live a full and productive life.”
Guests will also hear about the latest treatment options available for wet AMD, including a new anti-VEGF drug called Eylea® (aflibercept, VEGF Trap-Eye).
The event will be held at the Royal Victorian Eye and Ear Hospital in East Melbourne and is free to attend, however bookings are essential as there are limited places. Please call 1300 737 757 to book your place or email email@example.com no later than 15 October 2012.